The American Journal of Medicine
Volume 119, Issue 10, Supplement 1 , Pages 54-62 , October 2006

Surrogates of Mortality in Chronic Obstructive Pulmonary Disease

  • Claudia G. Cote, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Claudia G. Cote, MD, Bay Pines Veterans Administration Health Care System, 111 A, PO Box 5005, Bay Pines, Florida 33744.

References 

  1. Pauwels RA , Buist AS , Calverley PM , Jenkins CR , Hurd SS . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary . Am J Respir Crit Care Med . 2001;163:1256–1276
  2. Mannino DM , Homa DM , Akinbami LJ , Ford ES , Redd SC . Chronic obstructive pulmonary disease surveillance—United States, 1971–2000 . MMWR Surveill Summ . 2002;51:1–16
  3. Pauwels R . Global initiative for chronic obstructive lung diseases (GOLD): time to act . Eur Respir J . 2001;18:901–902
  4. Anthonisen NR , Wright EC , Hodgkin JE . Prognosis in chronic obstructive pulmonary disease . Am Rev Respir Dis . 1986;133:14–20
  5. Fletcher C , Peto R . The natural history of chronic airflow obstruction . BMJ . 1977;1:1645–1648
  6. Scanlon PD , Connett JE , Waller LA , Altose MD , Bailey WC , Buist AS . Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study . Am J Respir Crit Care Med . 2000;161:381–390
  7. Casaburi R , Mahler DA , Jones PW , et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease . Eur Respir J . 2002;19:217–224
  8. Decramer M , Celli B , Tashkin D , et al.  Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial . J Chron Obstruct Pulm Dis . 2004;1:303–312
  9. Gaissert HA , Trulock EP , Cooper JD , Sundaresan RS , Patterson GA . Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease . J Thorac Cardiovasc Surg . 1996;111:296–306
  10. Nishimura K , Izumi T , Tsukino M , Oga T . Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD . Chest . 2002;121:1434–1440
  11. Mahler DA , Donohue JF , Barbee RA , et al.  Efficacy of salmeterol xinafoate in the treatment of COPD . Chest . 1999;115:957–965
  12. O’Donnell DE , Lam M , Webb KA . Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 1998;158:1557–1565
  13. O’Donnell DE , Fluge T , Gerken F , et al.  Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD . Eur Respir J . 2004;23:832–840
  14. Guell R , Casan P , Belda J , et al.  Long-term effects of outpatient rehabilitation of COPD: a randomized trial . Chest . 2000;117:976–983
  15. Schols AM , Soeters PB , Dingemans AM , Mostert R , Frantzen PJ , Wouters EF . Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation . Am Rev Respir Dis . 1993;147:1151–1156
  16. Engelen MP , Schols AM , Baken WC , Wesseling GJ , Wouters EF . Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD . Eur Respir J . 1994;7:1793–1797
  17. Schols AM , Slangen J , Volovics L , Wouters EF . Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 1998;157:1791–1797
  18. Nocturnal Oxygen Therapy Trial Group . Continuous or nocturnal oxygen therapy in chronic obstructive lung disease: a clinical trial . Ann Intern Med . 1980;93:391–398
  19. Pinto-Plata VM , Cote C , Cabral H , Taylor J , Celli BR . The 6-min walk distance: change over time and value as a predictor of survival in severe COPD . Eur Respir J . 2004;23:28–33
  20. Fishman A , Martinez F , Naunheim K , et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema . N Engl J Med . 2003;348:2059–2073
  21. O’Donnell DE , Voduc N , Fitzpatrick M , Webb KA . Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease . Eur Respir J . 2004;24:86–94
  22. Cooper CB . Assessment of pulmonary function in COPD . Semin Respir Crit Care Med . 2005;26:246–252
  23. Casanova C , Cote C , de Torres JP , et al.  Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 2005;171:591–597
  24. Celli B , ZuWallack R , Wang S , Kesten S . Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes . Chest . 2003;124:1743–1748
  25. Similowski T , Agusti A , MacNee W , Schonhofer B . The potential impact of anaemia of chronic disease in COPD . Eur Respir J . 2006;27:390–396
  26. Chambellan A , Chailleux E , Similowski T . Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy . Chest . 2005;128:1201–1208
  27. Cote C , Zilberberg M , Mody S , Celli B . Anemia is a predictor of mortality in patients with COPD . Proc Am Thorac Soc . 2005;2:A890; [abstract]
  28. Goodnough LT , Nissenson AR . Anemia and its clinical consequences in patients with chronic diseases . Am J Med . 2004;116(suppl 7A):1S–2S
  29. Barnes PJ . Medical progress: chronic obstructive pulmonary disease . N Engl J Med . 2000;343:269–280
  30. Vernooy JH , Kucukaycan M , Jacobs JA , et al.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 2002;166:1218–1224
  31. Noguera A , Busquets X , Sauleda J , Villaverde JM , MacNee W , Agusti AGN . Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 1998;158:1664–1668
  32. Sin DD , Man SF . Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? . Thorax . 2006;61:1–3
  33. Yende S , Waterer GW , Tolley EA , et al.  Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning subjects . Thorax . 2006;61:10–16
  34. Broekhuizen R , Wouters EF , Creutzberg EC , Schols AM . Raised CRP levels mark metabolic and functional impairment in advanced COPD . Thorax . 2006;61:17–22
  35. Pinto-Plata V , Mullerova H , Toso J , et al.  C-reactive protein in patients with COPD, control smokers and non-smokers . Thorax . 2006;61:23–28
  36. Celli BR , Cote CG , Marin JM , et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease . N Engl J Med . 2004;350:1005–1012
  37. Cote C , Casanova C , Marin JM , et al.  The BODE index and the St (George’s Questionnaire: associations and survival in COPD) . Proc Am Thorac Soc . 2006;3:A851; [abstract]
  38. Cote C , Celli B . Effect of exacerbations of COPD on multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity: BODE index [abstract] . Chest . 2004;126:840S
  39. Ong KC , Earnest A , Lu SJ . A multidimensional grading system (BODE index) as predictor of hospitalizations for COPD . Chest . 2005;128:3810–3816
  40. Celli BR . Pulmonary rehabilitation for COPD: a practical approach for improving ventilatory conditioning . Postgrad Med . 1998;103:159–160 167–168, 173–176
  41. Cote CG , Celli BR . Pulmonary rehabilitation and the BODE index in COPD . Eur Respir J . 2005;26:630–636

PII: S0002-9343(06)00929-6

doi: 10.1016/j.amjmed.2006.08.008

The American Journal of Medicine
Volume 119, Issue 10, Supplement 1 , Pages 54-62 , October 2006

Article Tools

* Image Usage & Resolution